NOVEN FDA Tuesday, March 22, 2022 +0.80 Positive

FDA Approves Unknown Drug — NOVEN PHARMS INC

Noon Pharmaceuticals Inc. received FDA approval for a new agent on March 22, according to market intelligence sources. The company anticipates a significant boost to its revenue streams as the drug launches ahead of schedule.

View original filing at SEC.gov →
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.

Get real-time financial news in your trading bot or app

START FREE — 10,000 calls/day, no key needed